NBRV - Nabriva Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-5,3196,4823,767
Cost of Revenue82,28849,61547,99423,604
Gross Profit-72,632-44,296-41,512-19,837
Operating Expenses
Research Development----
Selling General and Administrative-29,47213,5357,921
Non Recurring----
Total Operating Expenses-79,08761,52931,525
Operating Income or Loss--73,768-55,047-27,758
Income from Continuing Operations
Total Other Income/Expenses Net-767-515-19,651
Earnings Before Interest and Taxes--73,768-55,047-27,758
Interest Expense--43-75-22,092
Income Before Tax--73,001-55,562-47,409
Income Tax Expense-1,355-672-445
Minority Interest----
Net Income From Continuing Ops--74,356-54,890-46,964
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--74,356-54,890-46,964
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--74,356-54,890-50,839